"Our technology not only efficiently addresses compliance and transparency needs, it also makes our clients more efficient, providing them with key strategic benefits," Bender explained.
Polaris develops innovative software platforms that simplify, streamline and automate processes to maximize efficiency and accuracy of compliance programs. Polaris' Global Compliance Platform is an integrated offering of Polaris' technology solutions, delivering complete workflow management, data capture and spend tracking and reporting of information related to all healthcare professional and organization payments and transfers of value.
The consulting experts at Polaris work with companies to define and map compliant processes, share industry best practices, establish policies then train teams to act in accordance with these procedures. Consultants measure and prioritize compliance risks using Polaris' proprietary methodology.
Polaris developed a Fair Market Value (FMV) methodology and rates for engaging with healthcare professionals in over 90 countries, and offers an online tool to efficiently provide access to rates and fees for services and manage the process.
"Several clients asked us to open an office in order to provide our compliance software and guidance to their businesses in the region," Bender stated. Hong Kong is the latest addition to the firm's global presence, joining offices in Amsterdam, Boston, New York, Paris and San Francisco.
Uniquely focused on the life sciences industry, Polaris delivers best-in-class solutions for today's toughest compliance challenges. The firm's services range from comprehensive technology and software solutions to expert consulting, strategy and planning, as well as end-to-end managed services. Since 2001, the world's most recognized pharmaceutical and medical device companies have relied on Polaris. www.polarismanagement.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/compliance-software-leader-polaris-expands-into-asiapac-providing-solutions-and-guidance-to-regions-life-sciences-companies-300326791.html